These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 12884202
1. Recurrent deep-vein thrombosis based on homozygous factor V Leiden mutation acquired after liver transplantation. Willems M, Sterneck M, Langer F, Jung R, Haddad M, Hagel C, Kuetemeier R, Eifrig B, Broering D, Fischer L, Rogiers X. Liver Transpl; 2003 Aug; 9(8):870-3. PubMed ID: 12884202 [Abstract] [Full Text] [Related]
3. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population. Torres JD, Cardona H, Alvarez L, Cardona-Maya W, Castañeda SA, Quintero-Rivera F, Cadavid A, Bedoya G, Tobón L. Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913 [Abstract] [Full Text] [Related]
5. Activated protein C resistance acquired through liver transplantation and associated with recurrent venous thrombosis. Leroy-Matheron C, Duvoux C, Van Nhieu JT, Leroy K, Cherqui D, Gouault-Heilmann M. J Hepatol; 2003 Jun; 38(6):866-9. PubMed ID: 12763384 [Abstract] [Full Text] [Related]
6. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation. González-Porras JR, García-Sanz R, Alberca I, López ML, Balanzategui A, Gutierrez O, Lozano F, San Miguel J. Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075 [Abstract] [Full Text] [Related]
15. Severe thrombotic complications associated with activated protein C resistance acquired by orthotopic liver transplantation. Gillis S, Lebenthal A, Pogrebijsky G, Levy Y, Eldor A, Eid A. Haemostasis; 2000 Jan; 30(6):316-20. PubMed ID: 11357000 [Abstract] [Full Text] [Related]
16. Mesenteric vein thrombosis due to factor V Leiden gene mutation. Bergenfeldt M, Svensson PJ, Borgström A. Br J Surg; 1999 Aug; 86(8):1059-62. PubMed ID: 10460643 [Abstract] [Full Text] [Related]
17. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis. Kim TW, Kim WK, Lee JH, Kim SB, Kim SW, Suh C, Lee KH, Lee JS, Seo EJ, Chi HS, Kim SH. J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165 [Abstract] [Full Text] [Related]
18. Factor V Arg306 --> Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese. Shen MC, Lin JS, Tsay W. Thromb Haemost; 2001 Feb; 85(2):270-3. PubMed ID: 11246546 [Abstract] [Full Text] [Related]